Creative Medical Technology Holdings (CELZ)
NASDAQ:CELZ
Total Valuation
Creative Medical Technology Holdings has a market cap or net worth of $7.91M. The enterprise value is -$1.69M.
Market Cap$7.91M
Enterprise Value-$1.69M
Share Statistics
Creative Medical Technology Holdings has 3,696,668 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding3,696,668
Owned by Insiders―
Owned by Institutions0.30%
Financial Efficiency
Creative Medical Technology Holdings’s return on equity (ROE) is -0.80 and return on invested capital (ROIC) is -81.64%.
Return on Equity (ROE)-0.80
Return on Assets (ROA)-0.77
Return on Invested Capital (ROIC)-81.64%
Return on Capital Employed (ROCE)-0.82
Revenue Per Employee1.50K
Profits Per Employee-1.50M
Employee Count4
Asset Turnover<0.01
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Creative Medical Technology Holdings is ―. Creative Medical Technology Holdings’s PEG ratio is 0.02.
PE Ratio―
PS Ratio778.38
PB Ratio0.62
Price to Fair Value0.62
Price to FCF-0.80
Price to Operating Cash Flow-0.87
PEG Ratio0.02
Income Statement
In the last 12 months, Creative Medical Technology Holdings had revenue of 6.00K and earned -6.00M in profits. Earnings per share was -2.52.
Revenue6.00K
Gross Profit-119.52K
Operating Income-6.14M
Pretax Income-6.00M
Net Income-6.00M
EBITDA-6.02M
Earnings Per Share (EPS)-2.52
Cash Flow
In the last 12 months, operating cash flow was -5.86M and capital expenditures 1.00, giving a free cash flow of -5.86M billion.
Operating Cash Flow-5.86M
Free Cash Flow-5.86M
Free Cash Flow per Share-1.58
Dividends & Yields
Creative Medical Technology Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.64
52-Week Price Change0.00%
50-Day Moving Average1.93
200-Day Moving Average2.66
Relative Strength Index (RSI)58.30
Average Volume (3m)147.04K
Important Dates
Creative Medical Technology Holdings upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Creative Medical Technology Holdings as a current ratio of 25.97, with Debt / Equity ratio of 0.00%
Current Ratio25.97
Quick Ratio25.97
Debt to Market Cap0.00
Net Debt to EBITDA1.20
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Creative Medical Technology Holdings has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Creative Medical Technology Holdings EV to EBITDA ratio is 0.42, with an EV/FCF ratio of 0.43.
EV to Sales-422.97
EV to EBITDA0.42
EV to Free Cash Flow0.43
EV to Operating Cash Flow0.43
Balance Sheet
Creative Medical Technology Holdings has $7.21M in cash and marketable securities with $0.00 in debt, giving a net cash position of $7.21M billion.
Cash & Marketable Securities$7.21M
Total Debt$0.00
Net Cash$7.21M
Net Cash Per Share$1.95
Tangible Book Value Per Share$2.99
Margins
Gross margin is -964.75%, with operating margin of -102380.23%, and net profit margin of -99916.80%.
Gross Margin-964.75%
Operating Margin-102380.23%
Pretax Margin-99916.80%
Net Profit Margin-99916.80%
EBITDA Margin-100324.78%
EBIT Margin-102380.23%
Analyst Forecast
The average price target for Creative Medical Technology Holdings is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―